STOCK TITAN

Bausch + Lomb Corporation Financials

BLCO
FY2025 annual
Revenue $5.1B +6.5% YoY
Net Income -$360.0M -13.6% YoY
EPS (Diluted) -$1.02 -13.3% YoY
Free Cash Flow -$66.0M -11.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Bausch + Lomb Corporation (BLCO) reported $5.1B in revenue for fiscal year 2025, up 6.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLCO FY2025

Revenue is expanding, but higher selling costs, a rising interest burden, and heavier reinvestment keep cash generation pinned down.

Interest expense reached $421M in FY2025 while operating income was only $113M, so reported losses are being shaped as much by financing structure as by operating softness. Meanwhile, operating cash flow recovered from -$17M in FY2023 to $283M in FY2025, yet free cash flow stayed negative because reinvestment rose with the business, so better cash conversion has not yet become surplus cash.

From FY2023 to FY2025, revenue climbed from $4.1B to $5.1B, but profit did not scale with it. The clearest sign is operating margin slipping from 3.1% to 2.2%, which points to weak fixed-cost absorption and a commercial cost structure still eating up growth.

Near-term liquidity looks workable, with a current ratio of 1.6x and cash of $383M. But long-term debt of $5.0B and goodwill equal to 33.9% of assets mean the balance sheet has less flexibility than the current ratio alone suggests.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 38 / 100
Financial Health Score 38/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Bausch + Lomb Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
47

Bausch + Lomb Corporation has an operating margin of 2.2%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 47/100, indicating healthy but not exceptional operating efficiency. This is down from 3.4% the prior year.

Growth
67

Bausch + Lomb Corporation's revenue grew 6.5% year-over-year to $5.1B, a solid pace of expansion. This earns a growth score of 67/100.

Leverage
5

Bausch + Lomb Corporation has elevated debt relative to equity (D/E of 0.78), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 5/100, reflecting increased financial risk.

Liquidity
42

Bausch + Lomb Corporation's current ratio of 1.55 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
25

While Bausch + Lomb Corporation generated $283.0M in operating cash flow, capex of $349.0M consumed most of it, leaving -$66.0M in free cash flow. This results in a low score of 25/100, reflecting heavy capital investment rather than weak cash generation.

Returns
43

Bausch + Lomb Corporation posts a -5.6% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 43/100. This is down from -4.9% the prior year.

Altman Z-Score Distress
0.87

Bausch + Lomb Corporation scores 0.87, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($6.1B) relative to total liabilities ($7.5B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Bausch + Lomb Corporation passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Bausch + Lomb Corporation reported a net loss of $360.0M while generating $283.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
0.27x

Bausch + Lomb Corporation earns $0.27 in operating income for every $1 of interest expense ($113.0M vs $421.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.1B
YoY+6.5%
5Y CAGR+8.4%

Bausch + Lomb Corporation generated $5.1B in revenue in fiscal year 2025. This represents an increase of 6.5% from the prior year.

EBITDA
$534.0M
YoY-10.7%
5Y CAGR-5.3%

Bausch + Lomb Corporation's EBITDA was $534.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.7% from the prior year.

Net Income
-$360.0M
YoY-13.6%

Bausch + Lomb Corporation reported -$360.0M in net income in fiscal year 2025. This represents a decrease of 13.6% from the prior year.

EPS (Diluted)
-$1.02
YoY-13.3%

Bausch + Lomb Corporation earned -$1.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 13.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$66.0M
YoY-11.9%

Bausch + Lomb Corporation recorded an outflow of $66.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 11.9% from the prior year.

Cash & Debt
$383.0M
YoY+25.6%
5Y CAGR+10.0%

Bausch + Lomb Corporation held $383.0M in cash against $5.0B in long-term debt as of fiscal year 2025.

Shares Outstanding
354M
YoY+0.5%

Bausch + Lomb Corporation had 354M shares outstanding in fiscal year 2025. This represents an increase of 0.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin
2.2%
YoY-1.2pp
5Y CAGR-5.4pp

Bausch + Lomb Corporation's operating margin was 2.2% in fiscal year 2025, reflecting core business profitability. This is down 1.2 percentage points from the prior year.

Net Margin
-7.1%
YoY-0.4pp
5Y CAGR-6.5pp

Bausch + Lomb Corporation's net profit margin was -7.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.4 percentage points from the prior year.

Return on Equity
-5.6%
YoY-0.7pp
5Y CAGR-5.4pp

Bausch + Lomb Corporation's ROE was -5.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$371.0M
YoY+8.2%
5Y CAGR+8.0%

Bausch + Lomb Corporation invested $371.0M in research and development in fiscal year 2025. This represents an increase of 8.2% from the prior year.

Capital Expenditures
$349.0M
YoY+19.9%
5Y CAGR+6.6%

Bausch + Lomb Corporation invested $349.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 19.9% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

BLCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BLCO annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20
Revenue$5.3B$5.1B+6.5%$4.8B+15.6%$4.1B+10.0%$3.8B+0.1%$3.8B+10.3%$3.4B
R&D Expenses$404.0M$371.0M+8.2%$343.0M+5.9%$324.0M+5.5%$307.0M+13.3%$271.0M+7.1%$253.0M
SG&A Expenses$2.2B$2.2B+7.3%$2.1B+19.9%$1.7B+17.5%$1.5B+6.4%$1.4B+10.9%$1.3B
Operating Income$323.0M$113.0M-30.2%$162.0M+24.6%$130.0M-37.2%$207.0M-37.1%$329.0M+26.5%$260.0M
Interest Expense$389.0M$421.0M+5.5%$399.0M+41.0%$283.0M+93.8%$146.0M$0$0
Income Tax$98.0M$35.0M-50.7%$71.0M-13.4%$82.0M+41.4%$58.0M-53.6%$125.0M-59.3%$307.0M
Net Income-$171.0M-$360.0M-13.6%-$317.0M-21.9%-$260.0M-4433.3%$6.0M-96.7%$182.0M+1111.1%-$18.0M
EPS (Diluted)-$1.02-13.3%-$0.90-21.6%-$0.74-3800.0%$0.02-96.2%$0.52+1140.0%-$0.05

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

BLCO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BLCO annual balance sheet
MetricFY25FY24FY23FY22FY21FY20
Total Assets$14.0B+4.1%$13.5B+0.2%$13.4B+20.6%$11.1B+3.0%$10.8BN/A
Current Assets$3.0B+6.8%$2.8B+1.7%$2.7B+28.3%$2.1B+30.7%$1.6BN/A
Cash & Equivalents$383.0M+25.6%$305.0M-7.9%$331.0M-6.5%$354.0M+103.4%$174.0M-26.9%$238.0M
Inventory$976.0M-5.8%$1.0B+0.8%$1.0B+63.7%$628.0M+9.8%$572.0MN/A
Goodwill$4.8B+5.2%$4.5B-1.1%$4.6B+1.5%$4.5B-1.7%$4.6B-2.1%$4.7B
Total Liabilities$7.5B+8.3%$6.9B+6.2%$6.5B+61.3%$4.0B+184.5%$1.4BN/A
Current Liabilities$1.9B+10.5%$1.7B+10.1%$1.6B+21.8%$1.3B+17.9%$1.1BN/A
Long-Term Debt$5.0B+5.8%$4.7B+4.7%$4.5B+88.0%$2.4B$0N/A
Total Equity$6.4B-0.4%$6.5B-5.5%$6.8B-2.6%$7.0B-24.6%$9.3B-6.6%$10.0B
Retained Earnings-$931.0M-63.0%-$571.0M-124.8%-$254.0M-4333.3%$6.0M$0N/A

Not reported in any period shown, so not listed: Accounts Receivable.

BLCO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

BLCO annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20
Operating Cash Flow$458.0M$283.0M+22.0%$232.0M+1464.7%-$17.0M-104.9%$345.0M-60.5%$873.0M+67.2%$522.0M
Capital Expenditures$321.0M$349.0M+19.9%$291.0M+60.8%$181.0M+3.4%$175.0M-9.3%$193.0M-23.7%$253.0M
Free Cash Flow$137.0M-$66.0M-11.9%-$59.0M+70.2%-$198.0M-216.5%$170.0M-75.0%$680.0M+152.8%$269.0M
Investing Cash Flow-$466.0M-$455.0M-10.4%-$412.0M+80.5%-$2.1B-880.9%-$215.0M-0.5%-$214.0M+16.4%-$256.0M
Financing Cash Flow$118.0M$225.0M+26.4%$178.0M-91.4%$2.1B+2465.4%$81.0M+111.4%-$712.0M-206.9%-$232.0M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

BLCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

BLCO annual financial ratios
MetricFY25FY24FY23FY22FY21FY20
Operating Margin2.2%-1.2pp3.4%+0.2pp3.1%-2.4pp5.5%-3.3pp8.7%+1.1pp7.6%
Net Margin-7.1%-0.4pp-6.6%-0.3pp-6.3%-6.4pp0.2%-4.7pp4.8%+5.4pp-0.5%
Return on Equity-5.6%-0.7pp-4.9%-1.1pp-3.8%-3.9pp0.1%-1.9pp1.9%+2.1pp-0.2%
Return on Assets-2.6%-0.2pp-2.4%-0.4pp-1.9%-2.0pp0.1%-1.6pp1.7%N/A
Current Ratio1.55-0.1x1.60-0.1x1.74+0.1x1.65+0.2x1.49N/A
Debt-to-Equity0.780.0x0.73+0.1x0.66+0.3x0.34+0.3x0.00N/A
FCF Margin-1.3%-0.1pp-1.2%+3.6pp-4.8%-9.3pp4.5%-13.6pp18.1%+10.2pp7.9%

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Frequently Asked Questions

What is Bausch + Lomb Corporation's annual revenue?

Bausch + Lomb Corporation (BLCO) reported $5.1B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Bausch + Lomb Corporation's revenue growing?

Bausch + Lomb Corporation (BLCO) revenue grew by 6.5% year-over-year, from $4.8B to $5.1B in fiscal year 2025.

Is Bausch + Lomb Corporation profitable?

No, Bausch + Lomb Corporation (BLCO) reported a net income of -$360.0M in fiscal year 2025, with a net profit margin of -7.1%.

Bausch + Lomb Corporation (BLCO) reported diluted earnings per share of -$1.02 for fiscal year 2025. This represents a -13.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bausch + Lomb Corporation (BLCO) had EBITDA of $534.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Bausch + Lomb Corporation (BLCO) had $383.0M in cash and equivalents against $5.0B in long-term debt.

Bausch + Lomb Corporation (BLCO) had an operating margin of 2.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Bausch + Lomb Corporation (BLCO) had a net profit margin of -7.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Bausch + Lomb Corporation (BLCO) has a return on equity of -5.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Bausch + Lomb Corporation (BLCO) recorded an outflow of $66.0M in free cash flow during fiscal year 2025. This represents a -11.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Bausch + Lomb Corporation (BLCO) generated $283.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Bausch + Lomb Corporation (BLCO) had $14.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Bausch + Lomb Corporation (BLCO) invested $349.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Bausch + Lomb Corporation (BLCO) invested $371.0M in research and development during fiscal year 2025.

Bausch + Lomb Corporation (BLCO) had 354M shares outstanding as of fiscal year 2025.

Bausch + Lomb Corporation (BLCO) had a current ratio of 1.55 as of fiscal year 2025, which is generally considered healthy.

Bausch + Lomb Corporation (BLCO) had a debt-to-equity ratio of 0.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Bausch + Lomb Corporation (BLCO) had a return on assets of -2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Bausch + Lomb Corporation (BLCO) has an Altman Z-Score of 0.87, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Bausch + Lomb Corporation (BLCO) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Bausch + Lomb Corporation (BLCO) reported a net loss of $360.0M while generating $283.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Bausch + Lomb Corporation (BLCO) has an interest coverage ratio of 0.27x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Bausch + Lomb Corporation (BLCO) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top